Holzmann, Klaus
[12]
Kinetics of expression analysis during mycmediated apoptosis
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Malignant transformation in vivo as well as in vitro requires the activation of oncogenes concomitant with the inactivation of tumor suppressor genes. Although data on the activities and functions of single oncogenes such as c-myc and c-Haras are abundant, less information is available on their synergistic action. We found that primary rat embryo cell lines transformed by c-myc and c-Ha-ras were prone to apoptosis after inhibition of MEK, a downstream kinase of the main Ras signaling pathway. Addition of the MEK1 inhibitor U0126 to a series of myc/rasexpressing cell lines uniformly resulted in unphosphorylated ERK1 and ERK2, morphological alterations and cell cycle arrest, and apoptosis occurred to various extents. The MR-6 cell line apoptosed most promptly after inhibition of MEK1. We analyzed in detail the kinetics of gene regulation of MR-6 cells during apoptosis by means of complementary DNA arrays for the expression of 1,200 characterized rat genes. A twofold increase in expression or reduction of expression below 50% was chosen as the threshold. More than 100 genes were found to be regulated during the early stage of apoptosis induction. One hour after addition of U0126, numerous growth factor receptor genes were induced. By 3 h, G1-or Sphase-specific genes, genes of the AP-1 transcription factor complex and genes coding for cell-surface antigens were upregulated. By 6 h, when MR-6 cells started to apoptose, the expression of most of them returned to baseline values. Data obtained with cDNA arrays were confirmed by northern and western blot analysis. The expression pattern and kinetics of gene regulation in U0126-treated MR-6 cells were compared with those of the MR-2 cell line, in which inhibition of MEK1 resulted in G1 arrest but not cell death. We conclude that myc-mediated apoptosis is accompanied by a transient wave of upregulation of a complex array of genes. At least some of them might represent an abortive attempt by cells to avert cell death. Many antineoplastic agents fail because of intrinsic or acquired resistance developed by the cancer cells; drug resistance is therefore a major obstacle to successful chemotherapy of human cancers, including ovarian cancer. Understanding the mechanisms by which drug resistance arises and identification of the molecular factors affecting new drug target development is of paramount importance. In a study to compare the global RNA expression profiles of primary and recurrent ovarian tumors from the same patient by means of oligonucleotide microarray analysis, we have identified XIST (inactive X [Xi] chromosome-specific transcripts) as the most differentially expressed gene that was downregulated in the recurrent tumor. The XIST gene resides within the X inactivation center and is unique in being expressed exclusively from the inactive X chromosome. XIST is both necessary and sufficient for X inactivation. Preliminary studies of the cell line derived from the recurrent tumor showed that the line is resistant to the antineoplastic agent taxol, one of the anticancer drugs included in the treatment of the patients under study. The recurrent cell line has at least one copy of XIST in the genome, although the gene is not expressed. Further characterization of XIST expression in a panel of ten ovarian cell lines and six breast cancer cell lines showed that the expression levels of XIST correlate significantly with taxol sensitivity. These data indicate a possible correlation between X inactivation and taxol resistance in ovarian cancer. We have launched a detailed mechanistic study to characterize the underlying mechanism.
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